# Nektar Therapeutics: Form 8-K, filed May 28, 2025

- Company: [Nektar Therapeutics](/companies/nktr.md) (CIK 906709)
- Form: 8-K
- Filed: 2025-05-28
- Accepted by EDGAR: May 27, 2025, 22:27 ET
- Period: 2025-05-23
- Accession: 0001213900-25-047890
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/906709/000121390025047890/ea0243394-8k_nektar.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/906709/000121390025047890/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/906709/000121390025047890/ea0243394-8k_nektar.htm

Filed May 28, 2025.
Source: SEC EDGAR, the filing index for accession 0001213900-25-047890. Last ingested by Listed: Oct 24, 2026, 15:00 ET. No prices; not investment advice.